UK and US agree to zero tariff deal on pharmaceuticals Business The government has agreed to a major deal with Washington that will see the UK become the only country to secure zero import tariffs on pharmaceutical products into the US for at least three years. The deal follows months of negotiations between the government and the Trump administration, after the June trade deal left the [...]
Astrazeneca injects $2bn to boost US manufacturing capabilities pharma FTSE 100 giant Astrazeneca plans to invest $2bn into growing its manufacturing footprint in Maryland, as part of its efforts to boost its US capabilities and presence. The investment will support the “significant expansion” of its biologics manufacturing facility in Frederick, doubling its capacity and increasing its medicine supply, as well as the construction of [...]
Astrazeneca vows to lower US medicine prices after pressure from Trump pharma Astrazeneca has bowed to pressure from US president Donald Trump to lower the cost of its medicines for patients in America. The Cambridge-based pharma giant said it will provide direct-to-consumer sales to eligible patients with prescriptions for chronic diseases at a discount of up to 80 per cent off list prices, alongside participating in the [...]
Ministers planning drug pricing shake-up to stem pharma exodus October 8, 2025 Ministers are drawing up a radical overhaul of NHS spending rules in a bid to shore up the UK’s world-leading life sciences industry after a string of pharma giants cancelled major UK investment projects. In what would amount to one of the largest shake-ups of NHS drug purchasing rules in recent history, the Prime Minister [...]
Astrazeneca to ‘upgrade’ US listing in latest blow to London Stock Exchange September 29, 2025 Astrazeneca has laid out plans aimed at “upgrading” its US listing in the latest blow to the London Stock Exchange. The Cambridge-based pharma giant said it would replace its existing Nasdaq listing of American Depositary Receipts (ADRs), a type of listing for trading overseas shares, with a direct listing of ordinary shares on the New [...]
GSK shares rally as chief Emma Walmsley to exit after eight years September 29, 2025 The chief executive of pharmaceutical giant GSK has announced plans to step down from the company at the end of the year. Emma Walmsley, who took the helm of the drugmaker in 2017, will be replaced by chief commercial officer Luke Miels. Miels – the former Executive Vice President of Astrazeneca – also joined the [...]
UK drug prices necessary to stop feud with companies, says science minister September 25, 2025 The price the NHS pays for medicines will need to rise to end the feud with pharmaceutical companies and stop the exodus of investment in the UK, science minister Patrick Vallance has said. Lord Vallance told the Financial Times that “all options” were on the table in terms of UK drug pricing, after several large [...]
Mounjaro sales help almost double Ely Lilly’s UK turnover September 18, 2025 The sale of weight loss drug Mounjaro has boosted the UK turnover of pharmaceuticals giant Eli Lilly by 90 per cent during its latest financial year, it has been revealed. The division of the US group has posted a turnover of £889m for 2024, according to new accounts filed with Companies House. The new total [...]
Why is the pharmaceutical industry turning its back on the UK? September 18, 2025 Since coming into power last year, Rachel Reeves and Keir Starmer have consistently stressed the importance of the life science sector to the UK economy, viewing it as critical for growth. In its aim to boost the industry’s standing, Labour pledged to make the UK an attractive place for investment and innovation, and to increase [...]
Astrazeneca pauses £200m Cambridge investment September 13, 2025 British drug giant Astrazeneca has paused a planned £200 million expansion of its research site in Cambridge in a fresh blow to the UK pharmaceutical industry. It comes after the pharmaceutical firm abandoned plans to invest £450 million in a vaccine plant in Merseyside earlier this year in a blow to the Government as it [...]